Our enthusiasm for healthcare allows us to stay ahead of developments. We understand the regulatory, reimbursement, technological, medical and patient environments locally and around the world. We know the key players and can take a global perspective on any M&A deal. We identify the right strategic partners, maximize synergy potential and realize great valuations for our clients.

We will work with commitment and dedication to achieve your aims.


Dedicated professionals


Deals closed


Live mandates

Global deals

Tombstone image
Tombstone image
Tombstone image
Tombstone image
Tombstone image

Healthcare specialists


South Africa, Johannesburg

Yaron Zimbler


Canada, Montreal

Pierre Mathieu

Mexico, Mexico City

Alejandro Rocha

United States, Cleveland

Andrew P. Male

United States, Jacksonville

Daniel Edelman

United States, Los Angeles

Jonathan Bluth

United States, New York

Michael S. Goldman

United States, Seattle

Scott Hardman

Asia Pacific

Australia, Sydney

Peter Fraser

China, Shanghai

John Zhang

Japan, Tokyo

Taro Okayama

Singapore, Singapore

Gerald Ong

Europe and Middle East

Austria, Vienna

Markus F. Bläuel

Belgium, Brussels

Nathalie Van Den Haute

Croatia, Zagreb

Željko Perić

Czech Republic, Prague

David Tajzich

Denmark, Copenhagen

Frederik Aakard

Estonia, Tallinn

Lauri Isotamm

Finland, Helsinki

Mikael Planting

France, Lyon

Francisco Diez

Germany, Hamburg

Christian Jellentrup

Ireland, Dublin

David Lyons

Israel, Tel Aviv

Boaz Levi

Italy, Milan

Federico Cappa

Latvia, Riga

Anna Aile

Netherlands, Amsterdam

Robert Boersma

Norway, Oslo

Odd Paulsen

Poland, Warsaw

Maciej Szalaj

Russia, Moscow

Alexey Bykov

Slovakia, Bratislava

Michal Staron

Spain, Madrid

José Antonio Martín de los Santos

Sweden, Stockholm

Sven-Åke Lewin

Switzerland, Bern

Roberto Tracia

Turkey, Istanbul

Levent Bosut

United Kingdom, London

Amanda Phillips

United Kingdom, London

Michael Jewell

Recent Oaklins news

Investment in the Italian dental market

DEAL FLASH: Oaklins’ team in Italy has advised Lifco AB, a Swedish investment group, on the acquisition of a majority stake in Rhein83 Srl. Lifco acquires and develops market-leading niche operations with the potential to deliver sustainable profit growth. Read more about the transaction, market trends, deal drivers and M&A valuation aspects.


Innovative medical device company executes its plan to become a global leader in respiratory care

DEAL FLASH: Oaklins’ team in Germany has advised the private shareholders of Acutronic Group, a group on non-affiliated companies active in neonatal ventilation and monitoring, on its sale to Apax-backed Vyaire Medical Inc. Vyaire and Acutronic are a perfect synergetic match, bringing together the sales force, resources and organizational excellence of a true multinational as well as the innovative spirit, flexibility and product portfolio of…


Leading medical nitinol tubing manufacturer joins medical contract manufacturing platform

DEAL FLASH: Oaklins’ team in Germany and our healthcare specialist in New York have advised the shareholders of Vascotube GmbH, a global manufacturer of high quality nitinol tubing, on the sale of the company to 3i-backed Cirtec Medical Systems, LLC. This acquisition aligns with Cirtec’s strategy to vertically integrate and expand its capabilities in minimally invasive interventional therapies. Read more about the transaction, market trends,…


Market leader and industry pioneer in genetic diagnostics acquired by global medical technology company

DEAL FLASH: Oaklins’ team in Los Angeles has advised the shareholders of Ambry Genetics Corporation, a clinical diagnostics testing services provider, on the sale of the company to Konica Minolta, Inc. This powerful combination will bring the most comprehensive genetic diagnostic solutions to Japan, Europe and globally. Read more about the transaction, market trends, deal drivers and M&A valuation aspects.


Oaklins’ team in Russia will join SFM Group at the BIO 2017

Our client, SFM Group, is going to attend the world’s largest global biotechnology event BIO 2017 International Convention taking place from 19–22 June 2017 in San Diego, USA. SFM Group, is an innovative Russian pharmaceutical company specializing in pharma R&D and has its own production facilities. Its product portfolio includes medicines to treat cardio-vascular diseases, viral infections, regenerative medicines, etc. Its breakthrough product is Trombovazim, a powerful thrombolytic…